Related Experiment Videos
Relation between hepatocellular carcinoma and persistent hepatitis B infection.
1Department of Pathology, Mount Sinai School of Medicine, City University of New York, N.Y.
Applied Pathology
|January 1, 1988
Summary
Chronic hepatitis B virus (HBV) infection is linked to hepatocellular carcinoma (HCC). Episodic inflammation in HBV carriers may promote HCC development, offering insights for managing this cancer precursor.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) is strongly associated with chronic hepatitis B virus (HBV) infection.
- HCC prevalence varies globally, with higher rates in the Far East and Africa.
- HBV vaccination offers a potential strategy for HCC elimination.
Purpose of the Study:
- To understand the mechanisms of hepatocarcinogenesis in the context of HBV infection.
- To investigate the role of necroinflammation in the development of HCC.
- To propose a hypothesis for HCC development in HBV carriers.
Main Methods:
- Integration of epidemiologic, morphologic, and animal model studies.
- Investigation of hepadna virus infections in woodchuck models.
- Clinical and molecular biologic studies of HCC development.
Main Results:
- Infection with HBV leads to HCC development in woodchuck models without external carcinogens.
- Permanent surface antigen carriers in the woodchuck model regularly develop HCC.
- A hypothesis suggests episodic necroinflammation acts as an endogenous cocarcinogen.
Conclusions:
- Episodic necroinflammation in the HBV carrier stage may promote HCC development.
- Disorganized integration of viral DNA during inflammation could lead to clonal HCC expansion.
- This hypothesis has implications for managing the HBV carrier state to prevent HCC.